Evaluation of the humoral response during ocrelizumab therapy in multiple sclerosis - an observational study
{{output}}
Introduction: Anti-CD20 monoclonal antibodies are widely used as high-efficacy treatment agents (HETAs) in multiple sclerosis (MS). In patients treated with ocrelizumab (OCR), reduced serum IgG levels are a common laboratory abno... ...
